Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Nature Communications|October 2, 2024
Molecular and functional landscape of malignant serous effusions for precision oncologyRebekka Wegmann, Lorenz Bankel, Yasmin Festl, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 30, 2020
EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinomaLimei Wang, Patrick Dorn, Cedric Simillion, et al.
Neurology|March 13, 2013
Emotion assessment using the NIH ToolboxJohn M Salsman, Zeeshan Butt, Paul A Pilkonis, et al.
European Journal of Human Genetics : EJHG|September 12, 2019
Correction: Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish populationDaniel L Polla, Elisa Rahikkala, Michaela K Bode, et al.
European Journal of Human Genetics : EJHG|March 28, 2019
Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish populationDaniel L Polla, Elisa Rahikkala, Michaela K Bode, et al.
Urologic Oncology|March 26, 2013
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordanceDavid E Victorson, Penny S Brucker, Rita K Bode, et al.
Science Advances|February 8, 2023
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevanceSara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
CD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lungLimei Wang, Patrick Dorn, Soheila Zeinali, et al.
Pageof 16